These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31782956)

  • 1. The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.
    Jodeleit H; Caesar J; Villarroel Aguilera C; Sterz S; Holdt L; Beigel F; Stallhofer J; Breiteneicher S; Bartnik E; Siebeck M; Gropp R
    Inflamm Bowel Dis; 2020 Mar; 26(4):557-569. PubMed ID: 31782956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.
    Jodeleit H; Winkelmann P; Caesar J; Sterz S; Holdt LM; Beigel F; Stallhofer J; Breiteneicher S; Bartnik E; Leeuw T; Siebeck M; Gropp R
    Dis Model Mech; 2021 Jan; 14(1):. PubMed ID: 33293281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals.
    Palamides P; Jodeleit H; Föhlinger M; Beigel F; Herbach N; Mueller T; Wolf E; Siebeck M; Gropp R
    Dis Model Mech; 2016 Sep; 9(9):985-97. PubMed ID: 27491073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD/scid IL-2Rγ
    Unterweger AL; Rüscher A; Seuß M; Winkelmann P; Beigel F; Koletzko L; Breiteneicher S; Siebeck M; Gropp R; Aszodi A
    Immun Inflamm Dis; 2021 Dec; 9(4):1631-1647. PubMed ID: 34499803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model.
    Jodeleit H; Palamides P; Beigel F; Mueller T; Wolf E; Siebeck M; Gropp R
    J Transl Med; 2017 Dec; 15(1):265. PubMed ID: 29282132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized NSG Mouse Models as a Preclinical Tool for Translational Research in Inflammatory Bowel Diseases.
    Weß V; Schuster-Winkelmann P; Karatekin YH; Malik S; Beigel F; Kühn F; Gropp R
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ulcerative colitis by suppressing glucose uptake with ritonavir.
    Jodeleit H; Al-Amodi O; Caesar J; Villarroel Aguilera C; Holdt L; Gropp R; Beigel F; Siebeck M
    Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30322872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD/Scid IL2Rγ
    Schindler M; Schuster-Winkelmann P; Weß V; Czell S; Rueff F; Wollenberg A; Siebeck M; Gropp R
    JID Innov; 2024 May; 4(3):100268. PubMed ID: 38736522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis.
    Jodeleit H; Milchram L; Soldo R; Beikircher G; Schönthaler S; Al-Amodi O; Wolf E; Beigel F; Weinhäusel A; Siebeck M; Gropp R
    PLoS One; 2020; 15(2):e0228615. PubMed ID: 32050001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.
    Nolte T; Zadeh-Khorasani M; Safarov O; Rueff F; Gülberg V; Herbach N; Wollenberg A; Mueller T; Siebeck M; Wolf E; Gropp R
    Clin Exp Immunol; 2013 May; 172(2):349-62. PubMed ID: 23574330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.
    Al-Amodi O; Jodeleit H; Beigel F; Wolf E; Siebeck M; Gropp R
    Inflamm Bowel Dis; 2018 May; 24(6):1225-1236. PubMed ID: 29788291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker.
    Föhlinger M; Palamides P; Mansmann U; Beigel F; Siebeck M; Gropp R
    J Transl Med; 2016 Nov; 14(1):310. PubMed ID: 27809916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Andrographolide affects Th1/Th2/Th17 responses of peripheral blood mononuclear cells from ulcerative colitis patients.
    Zhu Q; Zheng P; Zhou J; Chen X; Feng Y; Wang W; Zhou F; He Q
    Mol Med Rep; 2018 Jul; 18(1):622-626. PubMed ID: 29749556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
    Brehm MA; Kenney LL; Wiles MV; Low BE; Tisch RM; Burzenski L; Mueller C; Greiner DL; Shultz LD
    FASEB J; 2019 Mar; 33(3):3137-3151. PubMed ID: 30383447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.
    Belarif L; Danger R; Kermarrec L; Nerrière-Daguin V; Pengam S; Durand T; Mary C; Kerdreux E; Gauttier V; Kucik A; Thepenier V; Martin JC; Chang C; Rahman A; Guen NS; Braudeau C; Abidi A; David G; Malard F; Takoudju C; Martinet B; Gérard N; Neveu I; Neunlist M; Coron E; MacDonald TT; Desreumaux P; Mai HL; Le Bas-Bernardet S; Mosnier JF; Merad M; Josien R; Brouard S; Soulillou JP; Blancho G; Bourreille A; Naveilhan P; Vanhove B; Poirier N
    J Clin Invest; 2019 Apr; 129(5):1910-1925. PubMed ID: 30939120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.
    Fujii H; Luo ZJ; Kim HJ; Newbigging S; Gassas A; Keating A; Egeler RM
    PLoS One; 2015; 10(7):e0133216. PubMed ID: 26176698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
    Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
    Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
    Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
    Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
    J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.